Healthcare Industry News: Solos Endoscopy
News Release - May 25, 2006
Solos Endoscopy, Inc. Introduces New Instrumentation for the Ear, Nose, and Throat (ENT) MarketBOSTON, MA--(Healthcare Sales & Marketing Network)--May 25, 2006 -- Solos Endoscopy, Inc. (Other OTC:SLSE.PK ) is pleased to announce that the Company is introducing a new line of instruments for the Ear, Nose, and Throat (ENT) medical market. The ENT market represented over 1,000,000 procedures performed last year, with over 80% using endoscopic techniques.
Solos Endoscopy will look to offer a complete line of ENT instruments for the office and operating room. Development activity on additional products is underway and numerous new instruments are planned. Solos recognizes the fact that the distinctive design characteristics of its instruments will require a short learning curve, as the surgeon becomes familiar with the inherent advantages and performance characteristics unique to all Solos Endoscopy instruments.
Approximately 41% of all ENT procedures are currently performed as outpatient procedures. This number is expected to increase significantly in the years ahead. In addition, ENT surgeons are expanding their practice to include facial, plastic and reconstructive surgery. This market continues to rely heavily on instrumentation and video images for procedural recordings as well as documentation of all procedures, both in the operating room and more importantly in the office.
"We believe that the current trends in the ENT Endoscopic market will allow Solos Endoscopy to achieve its planned sales growth and expose a new customer base to the Solos brand and family of high quality products. Our state-of-the-art products will help specialists in this field to record information for insurance and teaching purposes, and perfecting their surgical techniques," stated Robert Segersten, President of Solos Endoscopy, Inc.
About Solos Endoscopy, Inc.
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.
Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Source: Solos Endoscopy
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.